PTAB

IPR2020-00040

Mylan Pharmaceuticals Inc v. Merck Sharp & Dohme Corp

General

Filed

10/30/19

Institution05/12/20

FWD--

Close05/07/21

StatusFinal Written Decision

OutcomePatentable

SourceUSPTO

Appeals21-2121, 21-2122, 21-2123

Administrative Patent Judges

Judge	Cases	Inst. Rate	FWD Inv. Rate
Roberta Pollock	400+	70%	70%
Sheridan K Snedden	500+	65%	75%
Timothy G Majors	100+	78%	69%

Petitioner

Party

Name	Ratings
Mylan Pharmaceuticals Inc	L5A
DR Reddy's Laboratories Ltd	L3D
DR Reddy's Laboratories Inc	L3D
Sun Pharmaceuticals Industries Ltd	L2B

Attorney

Name	Ratings
Goodwin Procter LLP	L5E
Keith A. Zullow	L3C
Winston Taylor LLP	L5E
Jovial Wong	L3E
Lerner David LLP	L4A
Michael H. Teschner	L4D
Tedd W. van Buskirk	L3A
Russell W. Faegenburg	L2B
Katten Muchin Rosenman LLP	L3C
Jitendra Malik	L4D
Lance Soderstrom	L3C
Alissa M. Pacchioli	L3D
Heike S. Radeke	L2C
Christopher West	L1C

Respondent

Party

Name	Ratings
Merck Sharp & Dohme Corp	L4B

Attorney

Name	Ratings
Williams & Connolly LLP	L5C
Jessamyn S. Berniker	L4A
Stanley E. Fisher	L4B
Shaun P. Mahaffy	L2B
Anthony Sheh	L2C